Factors influencing the number of sentinel lymph nodes identified in patients with breast cancer

Am J Surg. 2007 Dec;194(6):860-4; discussion 864-5. doi: 10.1016/j.amjsurg.2007.08.024.

Abstract

Background: Although the sentinel lymph node (SLN) is defined as the first node draining a tumor, multiple nodes are often identified. Few SLNs are required for adequate staging; removal of more may be unnecessary. The objective of this study was to determine factors influencing the number of SLN identified.

Methods: The University of Louisville Breast Sentinel Lymph Node Study was used to determine correlates of identifying greater than 4 SLNs by using univariate and multivariate analyses.

Results: An SLN was identified in 3,882 of 4,131 patients (94%). The median number of SLN identified was 2 (range 1-18); 90% had < or = 4 SLNs identified. Palpable tumors, surgeon inexperience, and dermal injection were associated with greater than 4 SLNs identified. All 3 of these factors remained significant on multivariate analysis.

Conclusions: Palpable tumors often have greater than 4 SLNs identified, and the use of intradermal injection increases this probability.

MeSH terms

  • Breast Neoplasms / pathology*
  • Carcinoma, Ductal, Breast / pathology*
  • Clinical Competence
  • Female
  • Humans
  • Injections, Intradermal
  • Logistic Models
  • Middle Aged
  • Multivariate Analysis
  • Sentinel Lymph Node Biopsy* / methods
  • Sentinel Lymph Node Biopsy* / standards